Controlled Substance Handling
UPM has a number of strict controls in place to ensure safe controlled substance packaging and handling of DEA Schedule I–V controlled substances and listed chemicals — chief among them being customer and staff education. As a controlled substances manufacturer, we take very seriously our responsibility to safely develop your product while navigating the regulatory pathway on your behalf. Working in close collaboration with customers, we ensure you not only understand all relevant Controlled Substances Act (CSA) regulations but also the specific implications of those regulations on your controlled drug product development and market strategy.
All UPM staff involved in controlled substance packaging and handling must undergo a rigorous training program to maintain compliance with CSA regulations while avoiding diversions and resulting development delays. In addition, we dedicate substantial R&D resources to investigating abuse-deterrence solutions promoted by both the DEA and FDA.
With over 15,800 square feet of DEA-approved vault space, an extensive track record of controlled substance manufacturing and positive, enduring relationships with regulators, UPM is a partner you can trust to safely advance your project from lab to
patient.
